Earnings, Squeeze Risk, and Index Clocks Flash Red

Earnings Drive the Headlines

Coinbase delivered mixed Q3 results but buried a standout figure: prediction markets hit $200 million in annualised revenue. That number grabbed attention across crypto desks. CareDx went further, lifting its full-year revenue guidance to $520 million to $530 million, up from $490 million to $500 million, and raising adjusted EBITDA guidance to $90 million to $100 million. Rivian added a positive note, with its CEO saying a far greater share of R2 reservation holders than expected are choosing the Launch Edition.

In Europe, Volkswagen and Renault both report today against a difficult backdrop. Austrian car registrations, which ORTEX Alt Data tracks as a leading indicator for VW revenue, are running 6% below the same quarter last year. Renault faces mixed signals: Austrian data points 6% higher, but Dutch registrations are running 19% lower year on year.

Short Squeeze Watch

Biohaven is the standout name in short-side data today. Its cost to borrow jumped 1,042% in a single week to 6.43%. Retail attention has surged simultaneously. That combination of rising borrow costs and growing retail interest is a classic precursor to squeeze pressure. Separately, COPT Defense Properties saw short interest climb 22.8% in one week to 9.0% of free float, the highest reading in months.

Russell Cut-off Today

Tomorrow is the ranking cut-off for the Russell 2000 December review. Health Catalyst sits exactly on the entry line at $135 million market cap. UWM Holdings needs just +0.4% to cross from the Russell 1000 into the 2000. On the deletion side, UMB Financial needs +6.3% to escape its exit line, with $1.2 billion of forced selling at stake if it falls through.

Analyst Moves

JP Morgan upgraded Constellium to Overweight after earnings cleared the picture, raising its target to $35 and implying 43% upside. RBC raised its target on Wingstop to $175, maintaining its Outperform rating.